In T2DM requiring insulin initiation, icodec titrated with an app safely reduced HbA<sub>1c</sub> vs. daily basal insulin analogues at 52 wk.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 38163368.
- Also identified by DOI 10.7326/J23-0110.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bajaj HS, Aberle J, Davies M, et al. <b>Once-weekly insulin icodec with dosing guide app versus once-daily basal insulin analogues in insulin-naive type 2 diabetes (ONWARDS 5): a randomized trial.</b> Ann Intern Med. 2023;176:1476-1485. 37748181.
Medical subject headings
- Diabetes Mellitus, Type 2
- Mobile Applications